mounjaro tirzepatide news today september 2025 Patients struggle to get weight loss drug ahead of price rise India | Eli Lilly has

Ferhatbegovi L et al

Contrave dosing starts low and builds up over four weeks, so be patient while your body adjusts

Therefore, increasing burden of cancer around the globe is expected to drive the growth for reduced glutathione, owing to its ability to protect cancer patients from the harmful side effects of chemotherapy

Mathevet, Genve (Gyncologie-obsttrique)

To summarize the last article: GLP-1 medications are reshaping modern medicine because they target the gut-brain-metabolic axis that drives most chronic disease - not just weight loss, but cardiovascular disease, heart failure, kidney disease, neurodegeneration, fatty liver, and systemic inflammation